Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Myriad signs five partnerships to study MRD testing in breast cancer
Clinical Trials Arena
Wednesday, October 9, 2024 - 10:13am
tags:
Myriad Genetics, MRD testing, breast cancer, Precise MRD, diagnostics
Five Crucial Trends Facing U.S. Drug Wholesalers in 2024 and Beyond
Drug Channels
Wednesday, October 9, 2024 - 10:11am
tags:
wholesalers, distribution
Cassava Sciences: Phase III trials storm ahead amid controversy
Clinical Trials Arena
Wednesday, October 9, 2024 - 9:56am
tags:
Cassave Sciences, clinical trials, simufilam, SEC
Boehringer unveils $607M deal to land Circle's preclinical cancer program
Fierce Biotech
Wednesday, October 9, 2024 - 9:55am
tags:
Boehringer Ingelheim, Circle Pharma, cancer, drug development
Biogen fills in some of the blanks on its trial of a high-dose version of Spinraza
Fierce Pharma
Wednesday, October 9, 2024 - 9:52am
tags:
Biogen, SMA, spinal muscular atrophy, Spinraza
Lilly, Insitro Ink Unique AI Deal, Eye Novel Treatments for Metabolic Diseases
BioSpace
Wednesday, October 9, 2024 - 9:46am
tags:
Insitro, Eli Lilly, siRNA, MASH
Roche CEO: breast cancer pill could enter $12 bln market if trials succeed
Reuters
Wednesday, October 9, 2024 - 9:44am
tags:
Roche, breast cancer, Giredestrant, clinical trials
As AI transforms drug development, biotechs might not need as much Big Pharma support
Pharma Voice
Wednesday, October 9, 2024 - 9:43am
tags:
biotech, artificial intelligence, Big Pharma, drug development
FDA knocks back Zealand's dasiglucagon once again
Pharmaphorum
Wednesday, October 9, 2024 - 9:42am
tags:
Zealand Pharma, dasiglucagon, congenital hyperinsulinism
Preparing for the US Biosecure Act - what does it mean for the pharma industry?
Outsourcing Pharma
Wednesday, October 9, 2024 - 9:40am
tags:
legislation, Biosecure Act, China
Sage continues downslide as Alzheimer’s study fails
BioPharma Dive
Tuesday, October 8, 2024 - 10:00pm
tags:
SAGE Therapeutics, Alzheimer's disease, clinical trials, SAGE-718
Mark Cuban is pushing his anti-PBM agenda with Kamala Harris — and it’s working
Stat
Tuesday, October 8, 2024 - 9:58pm
tags:
Mark Cuban, Kamala Harris, 2024 Presidential election, PBMs
'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout
Fierce Biotech
Tuesday, October 8, 2024 - 9:54pm
tags:
Pfizer, RSV, sisunatovir, ReViral
Pfizer, bracing for Hurricane Milton, pledges aid to emergency services and health support
Fierce Pharma
Tuesday, October 8, 2024 - 9:52pm
tags:
Pfizer, hurricane, Florida
Startup led by John Maraganore raises $135M to build ‘future of RNAi’
BioPharma Dive
Tuesday, October 8, 2024 - 9:50pm
tags:
City Therapeutics, funding, RNAi, John Maraganore
Execs, sale reps charged in $1.3B prescription drug operation
Beckers Hospital Review
Tuesday, October 8, 2024 - 9:49pm
tags:
DOJ, legal, opioids
GSK says RSV vaccine protects against disease over three seasons
BioPharma Dive
Tuesday, October 8, 2024 - 9:47pm
tags:
GSK, RSV, vaccines, clinical trials
Merck's Keytruda stages comeback in head and neck cancer with trial win in earlier-stage disease
Fierce Pharma
Tuesday, October 8, 2024 - 11:19am
tags:
Merck, clinical trials, Keytruda, head and neck cancer
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
Reuters
Tuesday, October 8, 2024 - 11:17am
tags:
GSK, Pfizer, RSV, vaccines
PTC puts Friedreich ataxia drug's past failures in the rearview with long-term data drop
Fierce Biotech
Tuesday, October 8, 2024 - 11:12am
tags:
PTC Therapeutics, Friedreich’s ataxia, vatiquinone

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.